心脏骤停复苏后昏迷患者早期静息态功能MRI活动改变:一项前瞻性队列研究
该前瞻性队列研究于2021年1月至2024年1月纳入31例心脏骤停复苏后昏迷患者和20例健康对照,在复苏后早期行rs-fMRI检查,用ALFF、fALFF和ReHo刻画区域神经活动,以3个月时Glasgow-Pittsburgh CPC量表评估神经功能结局。结果显示患者rs-fMRI活动呈复杂改变:部分脑区活动较健康对照增高、部分降低(P < 0.05),但全脑平均ALFF值在心脏骤停患者中显著更高(P = 0.011)。异常簇中,左侧颞中回及颞下回ALFF簇值与右侧中央前回、额上回及额中回ReHo簇值与CPC评分强相关(P < 0.001),全脑平均ALFF与SjvO2强相关(r = 0.910,P < 0.001),丘脑rs-fMRI活动与SSEP N20-基线波幅负相关(均P < 0.001)。作者认为异常BOLD信号与复苏后患者神经功能结局相关。
要点
- 31例心脏骤停复苏后昏迷患者早期rs-fMRI呈局部活动增高与降低并存的复杂改变(P < 0.05),全脑平均ALFF值显著高于健康对照(P = 0.011)。
- 左侧颞中回及颞下回ALFF簇值、右侧中央前回及额上回及额中回ReHo簇值与3个月CPC评分强相关(P < 0.001)。
- 全脑平均ALFF与颈静脉血氧饱和度(SjvO2)强相关(r = 0.910,P < 0.001)。
- 丘脑rs-fMRI活动与SSEP N20-基线波幅呈负相关(均P < 0.001)。
- 作者认为异常BOLD信号与复苏后患者神经功能结局相关。
适用人群与场景
- 2021年1月至2024年1月筛查的心脏骤停复苏后昏迷患者,纳入31例;另纳入20例健康对照。
- 神经功能结局于心脏骤停后3个月用Glasgow-Pittsburgh脑功能分级(CPC)量表评估。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入31例心脏骤停复苏后昏迷患者和20例健康对照,行rs-fMRI检查。
- 患者rs-fMRI活动呈复杂改变:部分局部脑区活动较健康对照增高、部分降低(P < 0.05)。
- 全脑平均ALFF值在心脏骤停患者中显著高于健康对照(P = 0.011)。
- 左侧颞中回及颞下回ALFF簇值、右侧中央前回及额上回及额中回ReHo簇值与CPC评分强相关(P < 0.001)。
- 心脏骤停患者全脑平均ALFF与SjvO2强相关(r = 0.910,P < 0.001)。
- 心脏骤停患者SSEP N20-基线波幅与丘脑rs-fMRI活动呈负相关(均P < 0.001)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,复苏后患者异常rs-fMRI BOLD信号与神经功能结局相关;全脑平均ALFF与SjvO2水平密切相关,丘脑BOLD信号改变与SSEP N20-基线波幅相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to explore the characteristics of abnormal regional resting-state functional magnetic resonance imaging (rs-fMRI) activity in comatose patients in the early period after cardiac arrest (CA), and to investigate their relationships with neurological outcomes. We also explored the correlations between jugular venous oxygen saturation (SjvO2) and rs-fMRI activity in resuscitated comatose patients. We also examined the relationship between the amplitude of the N20-baseline and the rs-fMRI activity within the intracranial conduction pathway of somatosensory evoked potentials (SSEPs).
METHODS: Between January 2021 and January 2024, eligible post-resuscitated patients were screened to undergo fMRI examination. The amplitude of low-frequency fluctuation (ALFF), fractional ALFF (fALFF), and regional homogeneity (ReHo) of rs-fMRI blood oxygenation level-dependent (BOLD) signals were used to characterize regional neural activity. Neurological outcomes were evaluated using the Glasgow-Pittsburgh cerebral performance category (CPC) scale at 3 months after CA.
RESULTS: In total, 20 healthy controls and 31 post-resuscitated patients were enrolled in this study. The rs-fMRI activity of resuscitated patients revealed complex changes, characterized by increased activity in some local brain regions and reduced activity in others compared to healthy controls (P < 0.05). However, the mean ALFF values of the whole brain were significantly greater in CA patients (P = 0.011). Among the clusters of abnormal rs-fMRI activity, the cluster values of ALFF in the left middle temporal gyrus and inferior temporal gyrus and the cluster values of ReHo in the right precentral gyrus, superior frontal gyrus and middle frontal gyrus were strongly correlated with the CPC score (P < 0.001). There was a strong correlation between the mean ALFF and SjvO2 in CA patients (r = 0.910, P < 0.001). The SSEP N20-baseline amplitudes in CA patients were negatively correlated with thalamic rs-fMRI activity (all P < 0.001).
CONCLUSIONS: This study revealed that abnormal rs-fMRI BOLD signals in resuscitated patients showed complex changes, characterized by increased activity in some local brain regions and reduced activity in others. Abnormal BOLD signals were associated with neurological outcomes in resuscitated patients. The mean ALFF values of the whole brain were closely related to SjvO2 levels, and changes in the thalamic BOLD signals correlated with the N20-baseline amplitudes of SSEP responses.
TRIAL REGISTRATION: NCT05966389 (Registered July 27, 2023).
参考来源
- Shao R, Wang T, Hang C, et al. Alteration in early resting‑state functional MRI activity in comatose survivors of cardiac arrest: a prospective cohort study. Crit Care. 2024. PMID: 39095884. doi:10.1186/s13054-024-05045-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。